Work

Osteoblastic Flare During Chemo-Immunotherapy in Small Cell Lung Cancer: Do Not Be Misleaded!

Year: 2023
Type: article
Study design: Case Report
Abstract: Introduction: "Osteoblastic flare" is defined as a temporary increase in bone tracer uptake associated with therapy response in patients without previously detected bone metastases.Hypothetically these apparently "new osteoblastic" lesions are not visible at baseline and are radiologically detected only after a bone sclerotic healing reaction has appeared, for this reason it does not indicate disease progression, but the healing of previously inconspicuous lesions.This phenomenon has been described in several solid tumours as response to antineoplastic treatments; however, it had never been reported in patients with ES-SCLC treated with chemo-immunotherapy. Methods:The Computed Tomography scans (CTs) of five patients with ES-SCLC treated with first-line chemo-immunotherapy with Atezolizumab, Carboplatin and Etoposide, were retrospectively reviewed to analyse the bone response to treatment compared with the response of the visceral tumour.Results: On reassessment CTs the development of new onset osteoblastic lesions was associated with a partial response in the other disease sites.In each case, osteoblastic lesions, developed during therapy, were considered as a response reflecting bone repair and efficacy of the treatment.Therefore, the maintenance therapy was continued obtaining a temporary stability of the disease.In view of the increasing use of chemo-immunotherapy in this setting, it is important not to confuse this phenomenon with disease progression, in order to avoid discontinuation of the maintenance immuno-therapy treatment, which the patient could benefit from.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: diamond
Estimated APC paid: $2,520
OpenAlex ID: W4384433334
FWCI:
Cites: 19
Cited by:
Related to: 10